INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Clinical trial / 2014

Effects of selenium and vitamin E supplementation on prostate cancer risk varied by baseline selenium status.

In a case-cohort analysis of the SELECT trial, researchers evaluated whether baseline toenail selenium modified the effects of selenium and vitamin E on prostate cancer (PCa) risk. Selenium supplementation did not affect risk in men with low baseline selenium (<60th percentile) but increased high-grade PCa risk by 91% (P = .007) in men with higher baseline selenium. Vitamin E alone had no effect in men with high baseline selenium (≥40th percentile) but increased risks of total (63%, P = .02) and high-grade PCa (111%, P = .008) among men with lower baseline selenium status.

Study type
Case-cohort study within a randomized trial
Who was studied
1739 total and 489 high-grade prostate cancer cases and 3117 men in a randomly selected subcohort from SELECT
What was measured
Total, low-grade, and high-grade (Gleason 7-10) prostate cancer risk

THE PAPER

Baseline selenium status and effects of selenium and vitamin e supplementation on prostate cancer risk.

Kristal AR, Darke AK, Morris JS, Tangen CM, Goodman PJ, Thompson IM, Meyskens FL, Goodman GE, Minasian LM, Parnes HL, Lippman SM, Klein EA. J Natl Cancer Inst, 2014.

PubMed 24563519 ↗DOI 10.1093/jnci/djt456 ↗

CancerNutrients & adequacy

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.